Results 71 to 80 of about 683 (135)

Azilsartan medoxomil for stage 2 systolic hypertension [PDF]

Nature Reviews Nephrology, 2012
openaire   +1 more source

A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum. [PDF]

Medicine (Baltimore), 2020
europepmc   +1 more source

558 AZILSARTAN MEDOXOMIL VS OLMESARTAN AND VALSARTAN

Journal of Hypertension, 2012
Stuart Kupfer, William B. White, Michael A. Weber, Domenic Sica, George L. Bakris, Eric Song, Alison Handley   +6 more
openaire   +2 more sources

A Systematic Literature Review and Network Meta-analysis of Azilsartan Medoxomil Compared to Other Anti-hypertensives Efficacy in Lowering Blood Pressure Amongst Mild to Moderate Hypertensive Patients. [PDF]

Adv Ther
Qian J, Zhang M, Chen Z.
europepmc   +1 more source

Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment. [PDF]

J Clin Pharmacol, 2018
Dudkowski C, Karim A, Zhao Z, Alonso AB, Garg D, Preston RA.   +5 more
europepmc   +1 more source

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension. [PDF]

J Hypertens, 2018
Cushman WC, Bakris GL, White WB, Weber MA, Sica D, Roberts A, Lloyd E, Kupfer S.   +7 more
europepmc   +1 more source

Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy. [PDF]

Core Evid, 2016
Angeloni E.
europepmc   +1 more source

Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed-Dose Combination in Healthy Adults. [PDF]

Clin Pharmacol Drug Dev, 2016
Dudkowski C, Karim A, Munsaka M.
europepmc   +1 more source

Effects of Age, Sex, and Race on the Safety and Pharmacokinetics of Single and Multiple Doses of Azilsartan Medoxomil in Healthy Subjects. [PDF]

Clin Pharmacokinet, 2016
Harrell RE, Karim A, Zhang W, Dudkowski C.   +3 more
europepmc   +1 more source

Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertension. [PDF]

J Clin Hypertens (Greenwich), 2015
Kipnes MS, Handley A, Lloyd E, Barger B, Roberts A.   +4 more
europepmc   +1 more source